| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/16/1997 | DE19627392A1 Medikament zur Verabreichung durch die Nase Medication to be administered through the nose |
| 01/16/1997 | DE19525607A1 Transcorneales Arzneimittelfreigabesystem Transcorneal drug release system |
| 01/16/1997 | DE19519056A1 Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation Use of antidepressants for the treatment of asthma and / or respiratory diseases using inhalational application |
| 01/16/1997 | CA2225444A1 Stable topical compositions |
| 01/16/1997 | CA2224381A1 Method of producing sustained-release preparation |
| 01/16/1997 | CA2222559A1 Encapsulated cells producing viral particles |
| 01/16/1997 | CA2197680A1 Lipophilic and amphiphilic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
| 01/15/1997 | EP0753340A2 Microcapsule manufacturing method using phospholipid |
| 01/15/1997 | EP0753312A1 Arteriosclerosis remedy |
| 01/15/1997 | EP0753311A1 Microemulsion preparation containing difficultly absorbable substance |
| 01/15/1997 | EP0753299A1 A formulation for iron chelation and a process for preparing same |
| 01/15/1997 | EP0753297A1 Lotion |
| 01/15/1997 | EP0753296A2 Oral formulations of S(+)-ibuprofen |
| 01/15/1997 | EP0753295A1 Use of deformable hollow particles against the photoblueing and/or the whitening of a cosmetic and/or dermatologic composition containing titanium oxide pigments |
| 01/15/1997 | EP0753262A2 Coating composition for preparing solid preparations and solid preparations |
| 01/15/1997 | EP0752997A1 Novel cationic phospholipids for transfection |
| 01/15/1997 | EP0752883A1 Use of mcp-1 for inducing ripening of the cervix |
| 01/15/1997 | EP0752877A1 Stabilized composition for oral administration of peptides |
| 01/15/1997 | EP0752866A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 01/15/1997 | EP0752865A1 Use of substituted dextrane for treating nervous system damage, and heparane sulphate-enriched fractions |
| 01/15/1997 | EP0752855A1 Use of fatty acid esters as bioadhesive substances |
| 01/15/1997 | EP0752852A1 Effervescent formulations of base coated acid particles |
| 01/15/1997 | EP0752851A1 New pharmaceutical formulation and process |
| 01/15/1997 | EP0752850A1 Pharmaceutical formulation |
| 01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
| 01/15/1997 | EP0752848A1 Pharmaceutical excipient having improved compressibility |
| 01/15/1997 | EP0752847A1 Ophthalmic composition with decreased viscosity |
| 01/15/1997 | EP0752838A1 STABLE SUPPOSITORY FORMULATIONS EFFECTING BIOVAILABILITY OF $g(D)?9 -THC |
| 01/15/1997 | EP0711172B1 Compositions of crataegus species, medicaments and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions |
| 01/15/1997 | EP0693926B1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 01/15/1997 | EP0642332B1 Ophthalmic compositions containing a cyclosporin |
| 01/15/1997 | EP0625178B1 Improved processes for the manufacture of enriched pitches and carbon fibers |
| 01/15/1997 | EP0597029B1 W/o microemulsions |
| 01/15/1997 | EP0594770B1 Oxicam or oxicam derivatives-containing ophthalmic compositions |
| 01/15/1997 | EP0440742B1 Liposome immunoadjuvants containing il-2 |
| 01/15/1997 | EP0372070B1 Method for making solvent dilution microcarriers |
| 01/15/1997 | CN1140412A Percutaneously absorbable preparation |
| 01/15/1997 | CN1140411A Oral liquid compositions contg. paroxetine resinate |
| 01/15/1997 | CN1140408A Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
| 01/15/1997 | CN1140407A Process for preparing solid pharmaceutical dosage forms |
| 01/15/1997 | CN1140406A Oil-in-water emulsions |
| 01/15/1997 | CN1140405A Lipophilic carrier preparations |
| 01/15/1997 | CN1140091A Bitterness-relieving agent |
| 01/15/1997 | CN1140088A Buccal tablet of human leucocyte interferon and preparing method thereof |
| 01/15/1997 | CN1140081A Burn scald medicinal oil |
| 01/15/1997 | CN1140079A Renewing medical powder and preparing method thereof |
| 01/15/1997 | CN1140078A Formula and producing process for fainting-relieving tablet |
| 01/15/1997 | CN1140077A Medical ointment (powder) for removing necrotic tissue and promoting tissue regeneration |
| 01/15/1997 | CN1140076A Anticancer capsule |
| 01/15/1997 | CN1140070A Hair-growing agent and its preparing process |
| 01/15/1997 | CN1140067A Turpinia pomifera capsule and its preparing process |
| 01/15/1997 | CN1140065A Formula of and preparing process for "Jiliukang" oral preparation for treatment of myoma |
| 01/15/1997 | CN1140062A Habit-breaking acupoint adhesive plaster for smokers |
| 01/15/1997 | CN1140058A Slow-release microsphere powder injection of androgenic hormone, its preparing method and use |
| 01/15/1997 | CN1140055A Slow-release preparation contg. isoptin and preparing process thereof |
| 01/14/1997 | US5594091 Polylactones for microcapsules |
| 01/14/1997 | US5594030 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/14/1997 | US5594013 Polyvinylpyrrolidone and an acrylic polymer, slow release |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593974 Localized oligonucleotide therapy |
| 01/14/1997 | US5593848 Target component assay utilizing specific gravity-altering liposomes |
| 01/14/1997 | US5593843 Stabilized microspheres and methods of preparation |
| 01/14/1997 | US5593824 Biological reagent spheres |
| 01/14/1997 | US5593697 Single dose vaccination system |
| 01/14/1997 | US5593696 Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders |
| 01/14/1997 | US5593695 Morphine therapy |
| 01/14/1997 | US5593694 Sustained release tablet |
| 01/14/1997 | US5593693 Effervescent mixture with alkali metal salts or lysinates of acidic, insoluble or slightly soluble active ingredients |
| 01/14/1997 | US5593691 Diesters and unsaturated diesters with cosmetics, drugs and tensides |
| 01/14/1997 | US5593690 Sustained release preparations |
| 01/14/1997 | US5593688 Liposomal targeting of ischemic tissue |
| 01/14/1997 | US5593687 Aqueous dispersion containing liposomes |
| 01/14/1997 | US5593686 Pharmaceutical compositions |
| 01/14/1997 | US5593685 Ranitidine compositions |
| 01/14/1997 | US5593684 Transdermal and transmucosal administration of nicotine at controlled levels in blood |
| 01/14/1997 | US5593675 Method of producing an anti-D immunoglobulin concentrate and a pharmaceutical preparation |
| 01/14/1997 | US5593663 Water insoluble liquid crystals for skins |
| 01/14/1997 | US5593661 Of lidocaine in a 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoropropane propellant |
| 01/14/1997 | US5593622 Preparation of liposomes with peg-bound phospholipid on surface |
| 01/14/1997 | US5593502 Method of making crystalline sugar and products resulting therefrom |
| 01/14/1997 | US5593440 Tissue implant systems and methods for sustaining viable high cell densities within a host |
| 01/14/1997 | US5592949 Vaginal diaphragm |
| 01/14/1997 | CA2046598C T-pa solubilisation |
| 01/14/1997 | CA2045680C High ibuprofen content granulations |
| 01/14/1997 | CA1338839C Controlled release formulation |
| 01/13/1997 | CA2180215A1 Medicament for nasal administration |
| 01/09/1997 | WO1997000703A1 Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments |
| 01/09/1997 | WO1997000697A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 01/09/1997 | WO1997000693A1 Novel formulation for peptide release |
| 01/09/1997 | WO1997000682A1 Compressed dry-granulation desogestrel tablets |
| 01/09/1997 | WO1997000681A1 Pharmaceutical composition containing lamotrigine |
| 01/09/1997 | WO1997000674A1 A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
| 01/09/1997 | WO1997000673A1 Process for the continuous agglomeration of granules |
| 01/09/1997 | WO1997000672A1 Nutritional and/or dietary composition and method of using the same |
| 01/09/1997 | WO1997000671A2 Composition for preparing finely dispersed systems and process for preparing the same |
| 01/09/1997 | WO1997000670A1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 01/09/1997 | WO1997000669A1 Compositions and methods for stabilizing polymers |
| 01/09/1997 | WO1997000668A1 Stable hydroalcoholic compositions |
| 01/09/1997 | WO1997000667A1 Stable hydroalcoholic compositions |
| 01/09/1997 | WO1997000666A1 Tar-containing composition and pharmaceutical and cosmetic preparation containing the same |